Amel Tounsi

Verified profile

Venture Capital, Investor · Belgium

Amel Tounsi is a venture capital investor and investor based in Belgium. They invest in Biotechnology and Pharmaceuticals, typically at the Seed stage. Their portfolio includes Amyl Therapeutics.

Investment stages

Industries

Portfolio companies (1)

  • Amyl Therapeutics

Similar investors in Biotechnology

  • Edouard Grutering

    Venture Capital · Belgium

    Health CareCRMLife ScienceAnalytics

    Portfolio: Ovizio, NGDATA

    Contact details available

  • AnVerified

    Private Equity Firm · Belgium

    Health CareTelecommunicationsE-commerceWomen Founded

    Portfolio: LaserComm, No Wires Needed

    Contact details available

  • Laurens Willems

    Venture Capital, Private Equity Firm · Belgium

    Health CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: Twikit, Ancoa Software

    Contact details available

  • Frederik BauwensVerified

    Family Investment Office · Belgium

    Health CareTelecommunicationsInvestment ManagementAndroid

    Portfolio: ProDigest, Greenbyte AB

    Contact details available

  • Ahmed Abdelhamid, Ph.D.

    Angel/Individual · Belgium

    Autonomous VehiclesInvestment ManagementLife ScienceManufacturing

    Portfolio: Nawah Scientific, Wright Electric Airplanes

    Contact details available

  • Johan Pede

    Venture Capital · Belgium

    Health CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: Bright Computing, Agendia

    Contact details available

  • Lien Callens

    Venture Capital, Accelerator, Private Equity Firm · Belgium

    Health CareWearablesTelecommunicationsWomen Founded

    Portfolio: MICLEDI Microdisplays, Onera

    Contact details available

  • Frank BulensVerified

    Venture Capital, Accelerator, Private Equity Firm · Belgium

    Health CareWearablesTelecommunicationsWomen Founded

    Portfolio: MICLEDI Microdisplays, Onera

    Contact details available